Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

ERN1 inhibitor

DRUG CLASS:

ERN1 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

ER positive + PGR negative	HER2 Negative Breast Cancer	ER positive + PGR negative	HER2 Negative Breast Cancer	ORIN1001 Sensitive: C4 – Case Studies ORIN1001 Sensitive : C4	ORIN1001 Sensitive: C4 – Case Studies ORIN1001 Sensitive : C4
FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	quizartinib + STF-083010 Sensitive: D – Preclinical quizartinib + STF-083010 Sensitive : D	quizartinib + STF-083010 Sensitive: D – Preclinical quizartinib + STF-083010 Sensitive : D
FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	STF-083010 Sensitive: D – Preclinical STF-083010 Sensitive : D	STF-083010 Sensitive: D – Preclinical STF-083010 Sensitive : D